The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas

Oral Oncology

Volumn 38, Issue 8, 2002, Pages 763-771

  Arai, Kazuo ^a   Shibahara, Takahiko ^a   Yamamoto, Nobuharu ^a   Noma, Hiroyasu ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Chromosome 3; Loss of heterozygosity (LOH); Microsatellite instability (MSI); Oral squamous cell carcinoma (SCC); Tumor suppressor gene

Indexed keywords

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER LOCALIZATION; CHROMOSOME 3P; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME MAP; CLINICAL ARTICLE; DELETION MUTANT; EARLY DIAGNOSIS; FEMALE; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; MICROSATELLITE INSTABILITY; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 0037004583     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(02)00068-4     Document Type: Article

References (42)

1. Fearon E.R. Tumor suppressor genes. Vogelstein B., Kinzker K.W. The genetic basis of human cancer. 1998;229-236 McGraw-Hill, New York.
2. Ishwad C.S., Ferrell R.E., Appel B.N., Johnson J.T., Myers E.N., Law J.C.et al. Microsatellite instability in oral cancer. Int J Cancer (Pred Oncol). 64:1995;332-335.
3. Ogawara K., Uzawa K., Nakanishi H., Yokoe H., Wang X.-L., Tanzawa H.et al. Frequent microsatellite instability in oral cancer. Oncol Rep. 4:1997;161-165.
4. Weinberg R.A. Tumor suppressor genes. Science. 254:1991;1138-1146.
5. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A.et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 60:1990;509-520.
6. Chiba I., Shindoh M., Yasuda M., Yamazaki Y., Amemiya A., Sato Y.et al. Mutations in the p53 gene and human papillomavirus infection as significant prognosis factors in squamous cell carcinomas of the oral cavity. Oncogene. 18:1996;1663-1668.
7. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M.et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
8. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E.et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353.
9. Kamb A., Shattuck-Eidens D., Eeles R., Liu Q., Gruis N.A., Ding W.et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet. 8:1994;23-26.
10. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I.et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
11. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J.et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 84:1996;587-597.
12. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A., Lin H., Ligon A.H.et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 15:1997;356-362.
13. Yakushiji T., Noma H., Shibahara T., Arai K., Yamamoto N., Tanaka C.et al. Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma. Bull Tokyo Dent Coll. 42:2001;159-168.
14. Imai F.L., Uzawa K., Miyakawa A., Shiiba M., Tanzawa H. A detailed deletion map of chromosome 20 in human oral squamous cell carcinoma. Int J Molecular Medicine. 7:2000;43-47.
15. Miyakawa A., Wang X.-L., Nakanishi H., Imai F.L., Shiiba M., Miya T.et al. Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol. 13:1998;705-719.
16. Nakanishi H., Wang X.-L., Imai F.L., Kato J., Shiiba M., Miya T.et al. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer. Anticancer Res. 19:1999;29-34.
17. Ogawara K., Miyakawa A., Shiiba M., Uzawa K., Watanabe T., Wang X.-L.et al. Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis. Int J Cancer. 79:1998;312-317.
18. Ono K., Miyakawa A., Fukuda M., Shiiba M., Uzawa K., Watanabe T.et al. Allelic loss on the short arm of chromosome 8 in oral squamous cell carcinoma. Oncol Rep. 6:1999;785-789.
19. Partridge M., Emilion G., Langdon J.D. LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. Br J Cancer. 73:1996;366-371.
20. Partridge M., Emilion G., Pateromichelakis S., Phillips E., Langdon J. Location of candidate tumor suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer. 83:1999;318-325.
21. Roz L., Wu C.L., Porter S., Scully C., Speight P., Read A.et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res. 56:1996;1228-1231.
22. Uzawa K., Suzuki H., Yokoe H., Tanzawa H., Sato K. Mutational state of p16/CDKN2 and VHL genes in squamous-cell carcinoma of the oral cavity. Int J Oncology. 7:1995;895-899.
23. Uzawa K., Suzuki H., Komiya A., Nakanishi H., Ogawara K., Tanzawa H.et al. Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int J Cancer. 67:1996;510-514.
24. Wang X.-L., Uzawa K., Imai Y., Tanzawa H. Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25. Oncogene. 18:1999;823-825.
25. Watanabe T., Wang X.-L., Miyakawa A., Shiiba M., Imai Y., Sato T.et al. Mutational state of tumor suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer. Int J Oncol. 11:1997;1287-1290.
26. Yamamoto N., Uzawa K., Miya T., Watanabe T., Yokoe H., Shibahara T.et al. Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: Evidence for three distinct tumor suppressor gene loci. Oncol Rep. 6:1999;1223-1227.
27. Arai K., Shibahara T., Yamamoto N., Yakushiji T., Tanaka C., Noma H. Frequent allelic loss/imbalance on the short arm of chromosome 3 in tongue cancer. Bull Tokyo Dent Coll. 42:2001;151-157.
28. Jones M.H., Nakamura Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene. 7:1992;1631-1634.
29. International Histological Classification of Tumours; Histological Typing of Oral and Oropharyngeal Tumours. No. 4. 1971;WHO, Geneva.
30. TNM Classification of Malignant Tumours. 4th edition:1987;Springer, Berlin.
31. Maniatis T., Fritsch E.F., Sambrook J. Molecular cloning; A laboratory manual edition 1. 1982;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
32. Komiya A., Suzuki H., Aida S., Yatani R., Shimazaki J. Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer. Jpn J Cancer Res. 86:1995;622-625.
33. Yamamoto E., Miyakawa A., Kohama G. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg. 6:1984;938-947.
34. Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L.et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1993;1317-1320.
35. Ah-See K.W., Cooke T.G., Pickford I.R., Soutar D., Balmain A. An allelotype of squamous cell carcinoma of the head and neck using microsatellite markers. Cancer Res. 54:1994;1617-1621.
36. Field J.K., Kiaris H., Risk J.M., Tsiriyotis C., Adamson R., Zoumpourlis V.et al. Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival. Br J Cancer. 72:1995;1180-1188.
37. Scully C., Field J.K. Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (Review). Int J Oncol. 10:1997;5-21.
38. Partridge M. The biology of cancer. Ward Booth P., Hausamen J.-E., Schendel S. Maxillofacial surgery (1st ed.). 1999;309-324 Churchill Livingstone, London.
39. Greenspan D.L., Connolly D.C., Wu R., Lei R.Y., Vogelstein J.T.C., Kim Y.-T.et al. Loss of FHIT expression in cervical carcinoma cell lines and primary tumor. Cancer Res. 57:1997;4692-4698.
40. Virgilio L., Shuster M., Gollin S.M., Veronese M.L., Ohta M., Huebner K.et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Nat Acad Sci (Wash). 93:1996;9770-9775.
41. Muller C.Y., O'Boyle J.D., Fong K.M., Wistuba I.I., Biesterveld E., Ahmadian M.et al. Abnormalities of fragile histidine trial genomic and complementary DNAs in cervical cancer: association with human papillomavirus subtype. J Nat Cancer Inst. 90:1998;433-439.
42. Mao L. Tumor suppressor genes: does FHIT fit? J Nat Cancer Inst. 90:1998;412-414.